ADNI | Publications

Filter results by:

1739 Total Publications

CSF Aβ1–42 – an excellent but complicated Alzheimer's biomarker – a route to standardisation
J. A. Kuhlmann, A. U., J. Pannee, M. Bjerke, E. Portelius, A. Leinenbach, T. Bittner, M. Korecka, R. G. Jenkins and Vanderstichele
PMID: 27216941 ; 2016; Journal Clinica Chimica Acta; vol. 467; pp. 27-33; doi:10.1016/j.cca.2016.05.014

Benzodiazepine Use Attenuates Cortical β-Amyloid and is Not Associated with Progressive Cognitive Decline in Nondemented Elderly Adults: A Pilot Study Using F18-Florbetapir Positron Emission Tomography.
J. K. Chung, S. Nakajima, S. Shinagawa, E. Plitman, M. M. Chakravarty, Y. Iwata, F. Caravaggio, B. G. Pollock, P. Gerretsen, A. Graff-Guerrero and I. Alzheimer's Disease Neuroimaging
PMID: 27538351 ; 2016; Journal Am J Geriatr Psychiatry; vol. 24; no. 11; pp. 1028-1039; doi:10.1016/j.jagp.2016.04.013

Quantitative Neuroimaging Software for Clinical Assessment of Hippocampal Volumes on MR Imaging
J. Ahdidan, C. A. Raji, E. A. DeYoe, J. Mathis, K. O. Noe, J. Rimestad, T. K. Kjeldsen, J. Mosegaard, J. T. Becker and O. Lopez
PMID: 26484924 ; PMCID:4718601 ; 2016; Journal J Alzheimers Dis; vol. 49; no. 3; pp. 723-32; doi:10.3233/JAD-150559

Manual segmentation of the fornix, fimbria, and alveus on high-resolution 3T MRI: Application via fully-automated mapping of the human memory circuit white and grey matter in healthy and pathological aging
R. S. C. Amaral, M. T. M. Park, G. A. Devenyi, V. Lynn, J. Pipitone, J. Winterburn, S. Chavez, M. Schira, N. J. Lobaugh, A. N. Voineskos, J. C. Pruessner, M. M. Chakravarty and I. Alzheimer's Disease Neuroimaging
PMID: 27765611 ; 2016; Journal Neuroimage; vol. 170; pp. 132-150; doi:10.1016/j.neuroimage.2016.10.027

Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort
D. Tosun, Y. F. Chen, P. Yu, K. L. Sundell, J. Suhy, E. Siemers, A. J. Schwarz, M. W. Weiner and I. Alzheimer's Disease Neuroimaging
PMID: 27109039 ; 2016; Journal Alzheimers Dement; vol. 12; no. 9; pp. 977-986; doi:10.1016/j.jalz.2016.03.009

Gene Prioritization for Imaging Genetics Studies Using Gene Ontology and a Stratified False Discovery Rate Approach
S. Patel, M. T. Park, M. M. Chakravarty and J. Knight
PMID: 27092072 ; PMCID:4823264 ; 2016; Journal Front Neuroinform; vol. 10; pp. 14; doi:10.3389/fninf.2016.00014

Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment
P. Suppa, H. Hampel, T. Kepp, C. Lange, L. Spies, J. B. Fiebach, B. Dubois, R. Buchert and I. Alzheimer's Disease Neuroimaging
PMID: 26923010 ; 2016; Journal J Alzheimers Dis; vol. 51; no. 3; pp. 867-73; doi:10.3233/JAD-150804

PETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET – Application to amyloid imaging with AV45-PET
G. Gonzalez-Escamilla, C. Lange, S. Teipel, R. Buchert, M. J. Grothe and I. Alzheimer's Disease Neuroimaging
PMID: 28039094 ; 2016; Journal Neuroimage; vol. 147; pp. 669-677; doi:10.1016/j.neuroimage.2016.12.077

Phantom criteria for qualification of brain FDG and amyloid PET across different cameras
Y. Ikari, G. Akamatsu, T. Nishio, K. Ishii, K. Ito, T. Iwatsubo and M. Senda
PMID: 27709546 ; PMCID:5052249 ; 2016; Journal EJNMMI Phys; vol. 3; no. 1; pp. 23; doi:10.1186/s40658-016-0159-y

White matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegeneration
B. M. Kandel, B. B. Avants, J. C. Gee, C. T. McMillan, G. Erus, J. Doshi, C. Davatzikos and D. A. Wolk
PMID: 27489875 ; PMCID:4950175 ; 2016; Journal Alzheimers Dement (Amst); vol. 4; pp. 18-27; doi:10.1016/j.dadm.2016.03.001